Format:
1 Online-Ressource (xii, 264 Seiten)
,
Illustrationen
ISBN:
9781780646534
,
9781780646541
Series Statement:
CABI Books
Content:
Intellectual Property Issues in Biotechnology -- Copyright -- Contents -- Contributors -- Foreword -- Preface -- 1: Biotechnology in Agriculture, Medicine and Industry: An Overview -- 1.1 Introduction -- 1.2 Biotechnology in Agriculture -- 1.3 Biotechnology in Industry -- 1.4 Biotechnology in Medicine -- 1.5 Conclusion -- References -- 2: Biotechnology and its Development in Developing Countries: Can Intellectual Property Rights Foster Innovation in the Field? -- 2.1 Introduction -- 2.2 The Concept of Biotechnology and the Legal Implications
Content:
2.3 Institutions, Legal Framework and Intellectual Property Law -- 2.4 Treaties, Conventions and Declarations in Brief -- 2.4.1 Declaration on the Human Genome and Human Rights -- 2.4.2 International Declaration on Human Genetic Data -- 2.4.3 The International Convention for the New Plant Varieties -- 2.4.4 Convention on Biological Diversity -- 2.4.5 Cartagena Protocol on Biosafety -- 2.4.6 The Nagoya Protocol on Access and Benefits Sharing -- 2.5 Biotechnology and Intellectual Property Rights as set out within TRIPS -- 2.6 China and India Revisited: Intellectual Property Rights and Biotechnology
Content:
2.6.1 China -- 2.6.2 India -- 2.7 Concluding and Comparative Remarks -- Notes -- References -- 3: Patent Eligibility Issues in Life Science Innovations: Contentious Court Cases -- 3.1 Introduction -- 3.2 Genetic Technology: The Beginning -- 3.3 Patent Eligibility of Diagnostic Procedures and Drug Dosing: The Case of Mayo Collaborative Services v. Prometheus Laboratories -- 3.4 Patenting Genetically Engineered Plant Seeds: The Doctrine of Patent Exhaustion and Self-Replicating Genetic Entities
Content:
3.5 Beyond Genetic Technology: Patent Eligibility Issues on Business Methods and Computer- Related Inventions -- 3.6 Patent Eligibility of Human Genes and Mutations: The Association for Molecular Pathology v. US PTO/Myriad Genetics -- 3.7 Why Is It Important to Allow Patenting of BRCA Gene Mutations? -- 3.8 India's IP Scenario -- 3.9 Patenting Human Stem Cells: Beyond the Legal Issues -- 3.10 Patent Eligibility Issues Involving Stem Cells Derived From Human Embryonic and Induced Pluripotent Stem Cells and Parthenogenesis -- 3.11 Patenting Parthenogenesis-Derived Stem Cells: Defining an Embryo
Content:
3.12 The Impact of the Court of Justice of the European Union Decision -- Notes -- References -- 4: Checks and Balances in Biotechnology-Related Patents: In Agreement to the Indian Patents (Amendment) Act, 2005 -- 4.1 Introduction -- 4.2 Checks and Balances Offered by Sections of The Indian Patents (Amendment) Act, 2005 -- 4.2.1 Section 2(1)(j) -- 4.2.2 Section 3(b) -- 4.2.3 Section 3(c) -- 4.2.4 Section 3(d) -- 4.2.5 Section 3(e) -- 4.2.6 Section 3(h) -- 4.2.7 Section 3(i) -- 4.2.8 Section 3(j) -- 4.2.9 Section 3(k) -- 4.2.10 Section 3(p) -- 4.2.11 Section 10(4) -- 4.2.12 Section 10(5)
Content:
4.3 Conclusion
Note:
Description based upon print version of record
Additional Edition:
ISBN 9781780646534
Additional Edition:
Print version Intellectual property issues in biotechnology Oxford : CABI,c2016
Language:
English
Keywords:
Biotechnologie
;
Patentschutz
;
Biotechnologie
;
Geistiges Eigentum
;
Electronic books
DOI:
10.1079/9781780646534.0000
Bookmarklink
